Results 141 to 150 of about 1,785 (194)

Clinical Outcomes of Omadacycline in Critically Ill Patients Treated for Carbapenem-Resistant Organism Infections: A Retrospective Study. [PDF]

Infect Drug Resist
Chen N, Xu Q, Song R, Luo Y, Xie L, Zhou J, Wang X.   +6 more
europepmc   +1 more source

Eravacycline and omadacycline Rescue multidrug-resistant Elizabethkingia anophelis: Triple-Model evaluation across in Vitro, Galleria mellonella, and murine bacteremia systems. [PDF]

J Adv Res
Hu S, Jiang L, Xu H, Meng X, Zhang D, Zhou D, Xiao Y, Zheng B.   +7 more
europepmc   +1 more source

Clinical Evaluation of Omadacycline for Pulmonary Mycobacterium <i>abscessus</i> Complex Infections: A Subgroup Analysis With a Focus on Macrolide Resistance. [PDF]

CHEST Pulm
Al Musawa M, El Ghali A, Bean R, Mammadova M, Wadle C, Muscarella A, Cimino C, Zeuli J, Howard C, Butt S, Mejia-Chew C, Kaip EA, Tupayachi-Ortiz MG, Fiske CT, Judd C, Caniff KE, Rybak MJ.   +16 more
europepmc   +1 more source

Efficacy and Safety of Tetracyclines in Bone and Joint Infections: A Literature Review. [PDF]

Infect Dis Ther
Laffont-Lozes P, Larcher R, Artiaga A, Lavigne JP, Loubet P, Sotto A.   +5 more
europepmc   +1 more source

Sulbactam-durlobactam plus ceftriaxone dosing and novel treatment regimens for <i>Mycobacterium abscessus</i> lung disease. [PDF]

Antimicrob Agents Chemother
Singh S, Shrivastava A, Boorgula GD, Long MC, Robbins B, McShane PJ, Gumbo T, Srivastava S.   +7 more
europepmc   +1 more source